DK1165071T3 - Forbedret cancerbehandling med temozolomid - Google Patents

Forbedret cancerbehandling med temozolomid

Info

Publication number: DK1165071T3
Authority: DK; Denmark
Prior art keywords: temozolomide; cancer treatment; improved cancer; improved; treatment
Prior art date: 1999-03-30

Application number

DK00918435T

Other languages

Danish (da)

English (en)

Inventor

Mohamed H Ragab

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-30

Filing date

2000-03-27

Publication date

2006-02-20

2000-03-27 Application filed by Schering Corp filed Critical Schering Corp

2006-02-20 Application granted granted Critical

2006-02-20 Publication of DK1165071T3 publication Critical patent/DK1165071T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK00918435T 1999-03-30 2000-03-27 Forbedret cancerbehandling med temozolomid DK1165071T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28134899A	1999-03-30	1999-03-30

Publications (1)

Publication Number	Publication Date
DK1165071T3 true DK1165071T3 (da)	2006-02-20

Family

ID=23076905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00918435T DK1165071T3 (da)	1999-03-30	2000-03-27	Forbedret cancerbehandling med temozolomid

Country Status (18)

Country	Link
EP (1)	EP1165071B1 (fr)
JP (2)	JP2002540148A (fr)
CN (2)	CN1345240A (fr)
AR (1)	AR023185A1 (fr)
AT (1)	ATE310515T1 (fr)
AU (1)	AU780892B2 (fr)
BR (1)	BR0009380A (fr)
CA (1)	CA2368614C (fr)
DE (1)	DE60024243T2 (fr)
DK (1)	DK1165071T3 (fr)
ES (1)	ES2251987T3 (fr)
HK (1)	HK1044111B (fr)
HU (1)	HUP0200805A3 (fr)
NO (1)	NO330651B1 (fr)
NZ (1)	NZ536302A (fr)
TW (1)	TWI276434B (fr)
WO (1)	WO2000057867A2 (fr)
ZA (1)	ZA200107736B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100366249C (zh) *	2002-09-29	2008-02-06	天津帝士力投资控股集团有限公司	一种替莫唑胺控释给药系统
CN1742723A (zh) *	2004-09-02	2006-03-08	天津倍方科技发展有限公司	含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) *	2004-10-14	2007-02-14	孔庆忠	一种抗癌药物组合物
JP2008519584A (ja) *	2004-11-09	2008-06-12	シェーリングコーポレイション	患者のｍｇｍｔレベルに基づいて癌を処置するための、テモゾロミドの改良された投薬養生法
ME02121B (fr) *	2006-01-17	2014-06-30	Abbvie Ireland Unlimited Co	Thérapie combinée comportant des inhibiteurs de PARP
AU2007233389C1 (en) *	2006-04-05	2013-07-25	Opko Health, Inc.	Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
AR061618A1 (es) *	2006-06-26	2008-09-10	Schering Corp	Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) *	2006-08-09	2008-02-28	Tian Jin Tasly Group Co., Ltd.	Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
KR101438036B1 (ko) *	2006-09-29	2014-09-04	씨아이피엘에이 엘티디.	테모졸로미드 및 유사체의 개선된 제조방법
WO2012075210A2 (fr) *	2010-12-01	2012-06-07	Niiki Pharma Inc.	Méthode de traitement du cancer réfractaire
CN102526038B (zh) *	2011-01-12	2013-09-11	北京人福军威医药技术开发有限公司	替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) *	2017-07-28	2020-07-10	东曜药业有限公司	一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT859630E (pt) *	1995-10-04	2003-02-28	Schering Corp	Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado
CA2184546A1 (fr) *	1996-07-31	1998-02-01	Margaret H. Dugan	Methode pour le traitement d'asotrocytomes a forte incidence pediatrique, incluant le gliome du tronc cerebral
CA2184545A1 (fr) *	1996-07-31	1998-02-01	Pascale Reidenberg	Traitement du cancer a l'aide de temozolomide

2000
- 2000-03-27 HU HU0200805A patent/HUP0200805A3/hu unknown
- 2000-03-27 AR ARP000101370A patent/AR023185A1/es unknown
- 2000-03-27 CN CN00805865A patent/CN1345240A/zh active Pending
- 2000-03-27 ES ES00918435T patent/ES2251987T3/es not_active Expired - Lifetime
- 2000-03-27 TW TW089105564A patent/TWI276434B/zh not_active IP Right Cessation
- 2000-03-27 DE DE60024243T patent/DE60024243T2/de not_active Expired - Lifetime
- 2000-03-27 EP EP00918435A patent/EP1165071B1/fr not_active Expired - Lifetime
- 2000-03-27 JP JP2000607618A patent/JP2002540148A/ja active Pending
- 2000-03-27 HK HK02103318.7A patent/HK1044111B/en not_active IP Right Cessation
- 2000-03-27 WO PCT/US2000/008079 patent/WO2000057867A2/fr not_active Ceased
- 2000-03-27 DK DK00918435T patent/DK1165071T3/da active
- 2000-03-27 CN CN2011100359769A patent/CN102160864A/zh active Pending
- 2000-03-27 BR BR0009380-7A patent/BR0009380A/pt not_active Application Discontinuation
- 2000-03-27 AT AT00918435T patent/ATE310515T1/de active
- 2000-03-27 CA CA002368614A patent/CA2368614C/fr not_active Expired - Fee Related
- 2000-03-27 AU AU39244/00A patent/AU780892B2/en not_active Ceased
- 2000-03-27 NZ NZ536302A patent/NZ536302A/en unknown
2001
- 2001-09-19 ZA ZA200107736A patent/ZA200107736B/xx unknown
- 2001-09-28 NO NO20014725A patent/NO330651B1/no not_active IP Right Cessation
2007
- 2007-03-20 JP JP2007073722A patent/JP2007169297A/ja active Pending

Also Published As

Publication number	Publication date
AU780892B2 (en)	2005-04-21
CN1345240A (zh)	2002-04-17
EP1165071B1 (fr)	2005-11-23
WO2000057867A2 (fr)	2000-10-05
HK1044111A1 (en)	2002-10-11
CN102160864A (zh)	2011-08-24
EP1165071A2 (fr)	2002-01-02
AU3924400A (en)	2000-10-16
CA2368614C (fr)	2008-07-22
WO2000057867A3 (fr)	2001-04-19
AR023185A1 (es)	2002-09-04
HUP0200805A2 (hu)	2002-07-29
BR0009380A (pt)	2001-12-26
JP2002540148A (ja)	2002-11-26
DE60024243T2 (de)	2006-08-17
ES2251987T3 (es)	2006-05-16
NZ536302A (en)	2006-05-26
TWI276434B (en)	2007-03-21
ZA200107736B (en)	2003-02-26
NO20014725L (no)	2001-11-13
CA2368614A1 (fr)	2000-10-05
HK1044111B (en)	2006-02-24
NO20014725D0 (no)	2001-09-28
NO330651B1 (no)	2011-05-30
HUP0200805A3 (en)	2004-07-28
DE60024243D1 (de)	2005-12-29
ATE310515T1 (de)	2005-12-15
JP2007169297A (ja)	2007-07-05

Publication	Publication Date	Title
NO20021400L (no)	2002-05-06	Terapeutiske kinazolinderivater
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
IL152754A0 (en)	2003-06-24	Quinazoline derivatives for the treatment of tumours
FI20000863A0 (fi)	2000-04-11	Uusi hoitomenetelmä
AR028476A1 (es)	2003-05-14	Tratamiento del cancer
EE200200571A (et)	2004-04-15	Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
DE60017816D1 (de)	2005-03-10	Herzschrittmacher
DE60023454D1 (de)	2005-12-01	Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20022245L (no)	2002-07-09	Onkolyttiske kombinasjoner for behandling av cancer
DE69916133D1 (de)	2004-05-06	Elektro-neuro-adaptiver stimulator
NO20020358D0 (no)	2002-01-23	Anvendelse av etodolac for behandling av kreft
DK1165071T3 (da)	2006-02-20	Forbedret cancerbehandling med temozolomid
DE60016600D1 (de)	2005-01-13	Herzschrittmacher
EE200200577A (et)	2004-06-15	Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et)	2004-02-16	Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
DE59911113D1 (de)	2004-12-23	Herzschrittmacher
NO20013337D0 (no)	2001-07-05	Ny behandling
NO20013596L (no)	2001-08-20	Slambehandling
DE60022086D1 (de)	2005-09-22	Wasserbehandlung
DE60013608D1 (de)	2004-10-14	Herzschrittmacher
DE60016452D1 (de)	2005-01-05	Herzschrittmacher
DE59908327D1 (de)	2004-02-19	Verformungskörper
SI1165071T1 (sl)	2006-04-30	Izboljsano zdravljenje raka s temozolomidom
NO20014850D0 (no)	2001-10-05	CML-terapi
DE50003427D1 (de)	2003-10-02	Rinnenkörper